secwatch.observer — SEC 8-K summary
======================================

Issuer:     Health Catalyst, Inc. (HCAT)
CIK:        0001636422
Form:       8-K
Filed at:   2024-02-22T23:59:59+00:00
Accession:  0001636422-24-000015
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01, 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Health Catalyst Q4 rev $75.1M (+9% YoY), FY rev $295.9M; CFO Hunt resigns, Alger named CFO; guides 2024 rev $304-312M
--------------------------------------------------------------------------------

- Q4 total revenue $75.1M, up 9% YoY; net loss $30.3M; adjusted EBITDA $1.4M (in line with guidance midpoint).
- FY2023 total revenue $295.9M, beat guidance midpoint; net loss $118.1M; adjusted EBITDA $11.0M (in line with guidance).
- 2024 guidance: revenue $304-312M; adjusted EBITDA $24-26M (~125%+ YoY growth at midpoint).
- CFO Bryan Hunt resigns effective March 1, replaced by CAO Jason Alger; Dan LeSueur appointed COO effective same date.
- Director Mark Templeton resigns effective March 1; 13,405 RSUs accelerated vesting; no disagreement cited.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000015/0001636422-24-000015-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636422/000163642224000015/hcat-20240216.htm
  HTML page:      https://secwatch.observer/filing/0001636422-24-000015

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer